Drugs like Ozempic (GLP-1 agonists) show promise for addiction treatment because they may reduce the fundamental 'wanting' of a substance, rather than just helping a person fight cravings. An addicted patient's core desire is often 'not to want,' and these drugs may directly address that by altering the brain's reward and satiety signaling.

Beyond weight loss, GLP-1s surprisingly curb addictive behaviors like drinking, smoking, and gambling. They work not by eliminating joy, but by reducing the pleasure derived from "one more" indulgence, effectively making people want less of these substances and activities.

Originally for diabetes, GLP-1s' broad positive effects on inflammation, heart, and brain function position them as the first mainstream drugs for human enhancement and longevity, moving beyond simple disease management.

While AI dominates headlines, GLP-1 drugs could have a more profound and immediate impact on society. They address the core mechanism of desire ("wanting less"), with applications for obesity, addiction, and compulsive behaviors that could fundamentally reshape public health and daily life.

Beyond direct physiological changes, GLP-1s help correct underlying physiology, which restores the mental and physical resources needed to maintain fundamentals like sleep, exercise, and nutrition. This secondary effect can be more profound than the drug's primary action.

The satiation signal from GLP-1s to the brain stem also down-regulates dopamine and the desire for it. This explains anecdotal reports and active studies on their effect in reducing cravings for nicotine, alcohol, shopping, and gambling.

GLP-1s are more than weight-loss aids; they are powerful anti-inflammatory agents affecting cardiovascular and neurological health. They even reduce cravings for things like gambling and cigarettes, acting as systemic moderators for entire biological systems, not just appetite.

Objecting to GLP-1s for outsourcing discipline is a flawed argument. Medicine has always sought to reduce human struggle, from anesthesia to antibiotics. Viewing GLP-1s as tools that improve biological function to free up human potential for other endeavors is consistent with this history.

The mechanism of drugs like Ozempic extends beyond appetite suppression. They interfere with the brain's dopamine-based neural reward system, making them effective not just for problematic eating but also for curbing other addictive behaviors including alcohol consumption, smoking, and even gambling.